内部人交易记录
高级管理人员尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Patel Sushil, 董事. Director active across 2 companies, notably Replimune Group, Inc.. Cumulatively, 23 disclosures have been published. Breakdown: 0 buy · 8 sells. Total volume traded: €1.5m. History available since 3 May 2021. The latest transaction was disclosed on 10 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Patel Sushil
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报23 总计
39,341 股@ US$12.97Common StockSEC:0001104659-26-095012:0
251,240 股0Common StockSEC:0001104659-26-040571:0
200,000 股0Common StockSEC:0001104659-25-123290:0
10,000 股@ US$11.139.2% 占其流量Common StockSEC:0001104659-25-118483:0
3,142 股0Common StockSEC:0001610717-25-000272:0
25,105 股@ US$8.0619.1% 占其流量Common StockSEC:0001104659-25-052143:0
166,667 股0Common StockSEC:0001104659-25-031835:0
10,000 股@ US$12.4212.6% 占其流量Common StockSEC:0001104659-24-129864:0
5,000 股@ US$24.8463.0% 占其流量Common StockSEC:0001610717-24-000516:0
2,155 股@ US$16.8018.4% 占其流量Common StockSEC:0001610717-24-000394:0
4,248 股0Common StockSEC:0001610717-24-000374:0
4,800 股0Common StockSEC:0001610717-24-000361:0
20,194 股@ US$6.4712.8% 占其流量Common StockSEC:0001104659-24-063559:0
2,155 股@ US$16.8018.6% 占其流量Common StockSEC:0001610717-24-000205:0
83,335 股0Common StockSEC:0001104659-24-043258:0
5,145 股@ US$24.1112.2% 占其流量Common StockSEC:0001104659-23-071772:0
5,200 股0Common StockSEC:0001610717-23-000131:0
15,575 股@ US$18.0527.5% 占其流量Common StockSEC:0001104659-23-062378:0
40,000 股0Common StockSEC:0001104659-23-041719:0
10,500 股0Common StockSEC:0001567619-22-013113:0
10,687 股@ US$14.590.035% mcap100.0% 占其流量Common StockSEC:0001104659-22-062607:0
52,500 股0Common StockSEC:0001104659-22-042768:0
88,333 股0Common StockSEC:0001104659-21-061913:0
About Patel Sushil
Patel Sushil is Chief Commercial Officer and Director. He has 22 filings in total, and in the sampled recent filings the activity consists only of sales, for a total of EUR 1036607 between 2021-05-05 and 2026-04-07. The main recent filings concern Replimune Group, Inc.